Pharmaceutical Raw Materials and Excipients No Further a Mystery
“The existing scenario has uncovered some structural weaknesses within the EU’s medicines supply chain plus a substantial dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She recommended that supply chain challenges be resolved in an EU pharmaceutical strategy envisioned being introdu